These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 16819789)
41. A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues. Foss GS; Nilsen R; Cornwell GC; Husby G; Sletten K Scand J Immunol; 1998 Apr; 47(4):348-54. PubMed ID: 9600316 [TBL] [Abstract][Full Text] [Related]
42. The intact human acetylcholinesterase C-terminal oligomerization domain is alpha-helical in situ and in isolation, but a shorter fragment forms beta-sheet-rich amyloid fibrils and protofibrillar oligomers. Cottingham MG; Voskuil JL; Vaux DJ Biochemistry; 2003 Sep; 42(36):10863-73. PubMed ID: 12962511 [TBL] [Abstract][Full Text] [Related]
43. Elongation in a beta-structure promotes amyloid-like fibril formation of human lysozyme. Goda S; Takano K; Yamagata Y; Maki S; Namba K; Yutani K J Biochem; 2002 Oct; 132(4):655-61. PubMed ID: 12359083 [TBL] [Abstract][Full Text] [Related]
44. Fibril formation of hsp10 homologue proteins and determination of fibril core regions: differences in fibril core regions dependent on subtle differences in amino acid sequence. Yagi H; Sato A; Yoshida A; Hattori Y; Hara M; Shimamura J; Sakane I; Hongo K; Mizobata T; Kawata Y J Mol Biol; 2008 Apr; 377(5):1593-606. PubMed ID: 18329043 [TBL] [Abstract][Full Text] [Related]
45. Tertiary structures of amyloidogenic and non-amyloidogenic transthyretin variants: new model for amyloid fibril formation. Schormann N; Murrell JR; Benson MD Amyloid; 1998 Sep; 5(3):175-87. PubMed ID: 9818054 [TBL] [Abstract][Full Text] [Related]
46. The distribution of residues in a polypeptide sequence is a determinant of aggregation optimized by evolution. Monsellier E; Ramazzotti M; de Laureto PP; Tartaglia GG; Taddei N; Fontana A; Vendruscolo M; Chiti F Biophys J; 2007 Dec; 93(12):4382-91. PubMed ID: 17766358 [TBL] [Abstract][Full Text] [Related]
47. Identification of an amyloidogenic region on keratoepithelin via synthetic peptides. Yuan C; Berscheit HL; Huang AJ FEBS Lett; 2007 Jan; 581(2):241-7. PubMed ID: 17207483 [TBL] [Abstract][Full Text] [Related]
48. Amyloidogenic peptide homologous to beta-domain region of alpha-lactalbumin. Egorov VV; Garmaj YP; Solovyov KV; Grudinina NA; Aleinikova TD; Sirotkin AK; Kiselev OI; Shawlovsky MM Dokl Biochem Biophys; 2007; 414():152-4. PubMed ID: 17695325 [No Abstract] [Full Text] [Related]
49. Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme. Kurochkin IV FEBS Lett; 1998 May; 427(2):153-6. PubMed ID: 9607302 [TBL] [Abstract][Full Text] [Related]
50. Amyloidogenic synthetic peptides of beta2-microglobulin--a role of the disulfide bond. Hasegawa K; Ohhashi Y; Yamaguchi I; Takahashi N; Tsutsumi S; Goto Y; Gejyo F; Naiki H Biochem Biophys Res Commun; 2003 Apr; 304(1):101-6. PubMed ID: 12705891 [TBL] [Abstract][Full Text] [Related]
51. Determination of Regions Involved in Amyloid Fibril Formation for Aβ(1-40) Peptide. Surin AK; Grigorashvili EI; Suvorina MY; Selivanova OM; Galzitskaya OV Biochemistry (Mosc); 2016 Jul; 81(7):762-9. PubMed ID: 27449623 [TBL] [Abstract][Full Text] [Related]
52. Structural characterization and biological properties of the amyloidogenic elastin-like peptide (VGGVG)3. Moscarelli P; Boraldi F; Bochicchio B; Pepe A; Salvi AM; Quaglino D Matrix Biol; 2014 Jun; 36():15-27. PubMed ID: 24686253 [TBL] [Abstract][Full Text] [Related]
53. Amyloidogenic sequences in native protein structures. Tzotzos S; Doig AJ Protein Sci; 2010 Feb; 19(2):327-48. PubMed ID: 20027621 [TBL] [Abstract][Full Text] [Related]
54. Proteins associated with diseases show enhanced sequence correlation between charged residues. Dima RI; Thirumalai D Bioinformatics; 2004 Oct; 20(15):2345-54. PubMed ID: 15073020 [TBL] [Abstract][Full Text] [Related]
55. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Goldschmidt L; Teng PK; Riek R; Eisenberg D Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3487-92. PubMed ID: 20133726 [TBL] [Abstract][Full Text] [Related]
56. Inhibition of amyloid fibril formation of human amylin by N-alkylated amino acid and alpha-hydroxy acid residue containing peptides. Rijkers DT; Höppener JW; Posthuma G; Lips CJ; Liskamp RM Chemistry; 2002 Sep; 8(18):4285-91. PubMed ID: 12298020 [TBL] [Abstract][Full Text] [Related]
57. Identification of Amyloidogenic Regions in the Spine of Insulin Fibrils. Surin AK; Grishin SY; Galzitskaya OV Biochemistry (Mosc); 2019 Jan; 84(1):47-55. PubMed ID: 30927525 [TBL] [Abstract][Full Text] [Related]
58. Insights into Stabilizing Forces in Amyloid Fibrils of Differing Sizes from Polarizable Molecular Dynamics Simulations. Davidson DS; Brown AM; Lemkul JA J Mol Biol; 2018 Oct; 430(20):3819-3834. PubMed ID: 29782833 [TBL] [Abstract][Full Text] [Related]
59. Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils. Marin-Argany M; Güell-Bosch J; Blancas-Mejía LM; Villegas S; Ramirez-Alvarado M Protein Sci; 2015 Nov; 24(11):1829-40. PubMed ID: 26300552 [TBL] [Abstract][Full Text] [Related]
60. Investigating by circular dichroism some amyloidogenic elastin-derived polypeptides. Tamburro AM; Lorusso M; Ibris N; Pepe A; Bochicchio B Chirality; 2010; 22 Suppl 1():E56-66. PubMed ID: 21038397 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]